Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Colistin in MDR Gram-Negative Infections
NCT02162966Phase 4Unknown
- Sponsor
- King Saud Medical City
- Start
- May 2014
- Primary completion
- Oct 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of colistin in Gram-negative bacterial infection, sponsored by King Saud Medical City. Status: unknown.
02
Drugs
colistin
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT02162966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162966.